BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1644 related articles for article (PubMed ID: 11884382)

  • 1. Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling.
    Mollnau H; Wendt M; Szöcs K; Lassègue B; Schulz E; Oelze M; Li H; Bodenschatz M; August M; Kleschyov AL; Tsilimingas N; Walter U; Förstermann U; Meinertz T; Griendling K; Münzel T
    Circ Res; 2002 Mar; 90(4):E58-65. PubMed ID: 11884382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of iNOS/sGC/PKG pathway, COX-2, CYP4A1, and gp91(phox) to the protective effect of 5,14-HEDGE, a 20-HETE mimetic, against vasodilation, hypotension, tachycardia, and inflammation in a rat model of septic shock.
    Tunctan B; Korkmaz B; Sari AN; Kacan M; Unsal D; Serin MS; Buharalioglu CK; Sahan-Firat S; Cuez T; Schunck WH; Manthati VL; Falck JR; Malik KU
    Nitric Oxide; 2013 Sep; 33():18-41. PubMed ID: 23684565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms underlying endothelial dysfunction in diabetes mellitus.
    Hink U; Li H; Mollnau H; Oelze M; Matheis E; Hartmann M; Skatchkov M; Thaiss F; Stahl RA; Warnholtz A; Meinertz T; Griendling K; Harrison DG; Forstermann U; Munzel T
    Circ Res; 2001 Feb; 88(2):E14-22. PubMed ID: 11157681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of in vivo nitroglycerin treatment on activity and expression of the guanylyl cyclase and cGMP-dependent protein kinase and their downstream target vasodilator-stimulated phosphoprotein in aorta.
    Mülsch A; Oelze M; Klöss S; Mollnau H; Töpfer A; Smolenski A; Walter U; Stasch JP; Warnholtz A; Hink U; Meinertz T; Münzel T
    Circulation; 2001 May; 103(17):2188-94. PubMed ID: 11331261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasodilator-stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide/cGMP signaling and endothelial dysfunction.
    Oelze M; Mollnau H; Hoffmann N; Warnholtz A; Bodenschatz M; Smolenski A; Walter U; Skatchkov M; Meinertz T; Münzel T
    Circ Res; 2000 Nov; 87(11):999-1005. PubMed ID: 11090544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NADPH oxidase accounts for enhanced superoxide production and impaired endothelium-dependent smooth muscle relaxation in BKbeta1-/- mice.
    Oelze M; Warnholtz A; Faulhaber J; Wenzel P; Kleschyov AL; Coldewey M; Hink U; Pongs O; Fleming I; Wassmann S; Meinertz T; Ehmke H; Daiber A; Münzel T
    Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1753-9. PubMed ID: 16763163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nebivolol inhibits superoxide formation by NADPH oxidase and endothelial dysfunction in angiotensin II-treated rats.
    Oelze M; Daiber A; Brandes RP; Hortmann M; Wenzel P; Hink U; Schulz E; Mollnau H; von Sandersleben A; Kleschyov AL; Mülsch A; Li H; Förstermann U; Münzel T
    Hypertension; 2006 Oct; 48(4):677-84. PubMed ID: 16940222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional and biochemical analysis of endothelial (dys)function and NO/cGMP signaling in human blood vessels with and without nitroglycerin pretreatment.
    Schulz E; Tsilimingas N; Rinze R; Reiter B; Wendt M; Oelze M; Woelken-Weckmüller S; Walter U; Reichenspurner H; Meinertz T; Münzel T
    Circulation; 2002 Mar; 105(10):1170-5. PubMed ID: 11889009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nebivolol prevents vascular NOS III uncoupling in experimental hyperlipidemia and inhibits NADPH oxidase activity in inflammatory cells.
    Mollnau H; Schulz E; Daiber A; Baldus S; Oelze M; August M; Wendt M; Walter U; Geiger C; Agrawal R; Kleschyov AL; Meinertz T; Münzel T
    Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):615-21. PubMed ID: 12692005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel gp91(phox) homologues in vascular smooth muscle cells : nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways.
    Lassègue B; Sorescu D; Szöcs K; Yin Q; Akers M; Zhang Y; Grant SL; Lambeth JD; Griendling KK
    Circ Res; 2001 May; 88(9):888-94. PubMed ID: 11348997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Superoxide production and expression of NAD(P)H oxidases by transformed and primary human colonic epithelial cells.
    Perner A; Andresen L; Pedersen G; Rask-Madsen J
    Gut; 2003 Feb; 52(2):231-6. PubMed ID: 12524405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of vasodilator-stimulated phosphoprotein: a consequence of nitric oxide- and cGMP-mediated signal transduction in brain capillary endothelial cells and astrocytes.
    Sporbert A; Mertsch K; Smolenski A; Haseloff RF; Schönfelder G; Paul M; Ruth P; Walter U; Blasig IE
    Brain Res Mol Brain Res; 1999 Apr; 67(2):258-66. PubMed ID: 10216224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase.
    Guzik TJ; Mussa S; Gastaldi D; Sadowski J; Ratnatunga C; Pillai R; Channon KM
    Circulation; 2002 Apr; 105(14):1656-62. PubMed ID: 11940543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of NAD(P)H oxidases by thromboxane A2 receptor uncouples endothelial nitric oxide synthase.
    Zhang M; Song P; Xu J; Zou MH
    Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):125-32. PubMed ID: 20947827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does nitric oxide mediate the vasodilator activity of nitroglycerin?
    Kleschyov AL; Oelze M; Daiber A; Huang Y; Mollnau H; Schulz E; Sydow K; Fichtlscherer B; Mülsch A; Münzel T
    Circ Res; 2003 Oct; 93(9):e104-12. PubMed ID: 14551241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NAD(P)H oxidase inhibition improves endothelial function in rat and human blood vessels.
    Hamilton CA; Brosnan MJ; Al-Benna S; Berg G; Dominiczak AF
    Hypertension; 2002 Nov; 40(5):755-62. PubMed ID: 12411473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perivascular superoxide anion contributes to impairment of endothelium-dependent relaxation: role of gp91(phox).
    Rey FE; Li XC; Carretero OA; Garvin JL; Pagano PJ
    Circulation; 2002 Nov; 106(19):2497-502. PubMed ID: 12417549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of blood vessel vasodilator-stimulated phosphoprotein at serine 239 as a functional biochemical marker of endothelial nitric oxide/cyclic GMP signaling.
    Ibarra-Alvarado C; Galle J; Melichar VO; Mameghani A; Schmidt HH
    Mol Pharmacol; 2002 Feb; 61(2):312-9. PubMed ID: 11809855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitroxyl (HNO) stimulates soluble guanylyl cyclase to suppress cardiomyocyte hypertrophy and superoxide generation.
    Lin EQ; Irvine JC; Cao AH; Alexander AE; Love JE; Patel R; McMullen JR; Kaye DM; Kemp-Harper BK; Ritchie RH
    PLoS One; 2012; 7(4):e34892. PubMed ID: 22506056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase C.
    Heitzer T; Wenzel U; Hink U; Krollner D; Skatchkov M; Stahl RA; MacHarzina R; Bräsen JH; Meinertz T; Münzel T
    Kidney Int; 1999 Jan; 55(1):252-60. PubMed ID: 9893134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 83.